MARKET

AMLX

AMLX

Amylyx Pharmaceuticals
NASDAQ
14.11
+0.21
+1.51%
Opening 10:19 04/01 EDT
OPEN
14.17
PREV CLOSE
13.90
HIGH
14.66
LOW
13.88
VOLUME
187.84K
TURNOVER
--
52 WEEK HIGH
17.49
52 WEEK LOW
3.110
MARKET CAP
1.56B
P/E (TTM)
-9.2192
1D
5D
1M
3M
1Y
5Y
1D
Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga · 5h ago
A Look At Amylyx Pharmaceuticals (AMLX) Valuation After LUCIDITY Phase 3 Trial Reaches Full Enrollment
Simply Wall St · 2d ago
Weekly Report: what happened at AMLX last week (0323-0327)?
Weekly Report · 2d ago
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital
TipRanks · 4d ago
Analysts Are Bullish on These Healthcare Stocks: Repligen (RGEN), Amylyx Pharmaceuticals Inc (AMLX)
TipRanks · 03/25 16:50
Amylyx Pharmaceuticals Price Target Maintained With a $34.00/Share by HC Wainwright & Co.
Dow Jones · 03/25 10:45
Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and Medtronic (MDT)
TipRanks · 03/25 10:40
HC Wainwright & Co. Reiterates Buy on Amylyx Pharmaceuticals, Maintains $34 Price Target
Benzinga · 03/25 10:35
More
About AMLX
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on three investigational therapies across several neurodegenerative and endocrine diseases. Its lead investigational asset is avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist. Avexitide has been evaluated as a treatment for Post-Bariatric Hypoglycemia (PBH) and congenital HI, two indications characterized by hyperinsulinemic hypoglycemia. In addition to avexitide, it is advancing AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol in Wolfram syndrome and progressive supranuclear palsy (PSP), and AMX0114 in amyotrophic lateral sclerosis (ALS). AMX0035 is designed to mitigate neurodegeneration by targeting endoplasmic reticulum stress and mitochondrial dysfunction, two cellular processes central to neuronal cell death and neurodegeneration. AMX0114 is an investigational antisense oligonucleotide.

Webull offers Amylyx Pharmaceuticals Inc stock information, including NASDAQ: AMLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMLX stock methods without spending real money on the virtual paper trading platform.